Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative.
Chowdary D, Lathrop J, Skelton J, Curtin K, Briggs T, Zhang Y, Yu J, Wang Y, Mazumder A
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to compare gene expression analysis by microarray of snap-frozen and RNA-later preserved breast and colon tumors.
Summary of Findings
No significant differences in RNA yield or integrity were found between snap-frozen and RNAlater-preserved breast and colon specimens. The Pearson's correlation coefficient of snap-frozen and RNAlater-preserved specimens was 0.98 for breast tumors and 0.96 for colon tumors. After mutiple testing and correction for false discovery, a comparison of expression of snap-frozen and RNAlater-preserved specimens identified only 2 genes to be differentially expressed between preservation methods in breast tumors and no genes significantly different in colon tumors. Further, the ratio of the hybridization signal from snap-frozen and RNAlater-preserved specimens for each gene was found to be close to 1 and hierarchical clustering could not distinguish between the two preservation methods. When breast tissue was compared with colon tissue, 70% of the genes found to be up-or down regulated between tissue types were identified in both snap-frozen and RNAlater preserved tissues. Finally, the prediction of recurrence was similar between frozen and RNAlater-preserved tissues with 97% agreement for breast tumors and 95% agreement for colon tumors. In conclusion, RNAlater may be used for preservation of tissue specimens for microarray analysis.
Biospecimens
TissueBreastTissueColorectalPreservation Types
RNAlaterFrozenDiagnoses
NeoplasticCarcinomaPlatforms
RNASpectrophotometryRNAAutomated electrophoresis/BioanalyzerRNADNA microarrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location BreastColonBiospecimen Preservation Type of fixation/preservation RNAlaterSnap frozen